Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

View:
Post by SABBOBCAT on Dec 05, 2022 8:49am

Wierd

So you'd think woth disappointing news you'd do the late evening PR late on the week to do it as quietly as possible. While TH did the late night thing, they didn't do it quietly and blasted it across every social media account on English and French. Something seems off about the whole situation and strategy here.
Comment by Bucknelly21 on Dec 05, 2022 9:05am
The only thing off about thera is everything, no clue how to deliver anything to the market or interact properly. One of the most mismanaged companies as far as dealing with markets and shareholders i have ever seen
Comment by houbahop on Dec 05, 2022 4:28pm
Beware Bucknelly, you will be put on ignore by Thera Fan Club.
Comment by Wino115 on Dec 05, 2022 9:14am
For what it's worth, IR said there were systemwide newswire glitches when they went to release.That's why they used NASDAQ filing  as a backup until PR firm fixed their issue. I've noticed new IR and PR women have been more consistent in getting news on more platforms. Not a bad thing to do. On another note, there still appear to be a lot of followers up here as my post got ...more  
Comment by jfm1330 on Dec 05, 2022 9:29am
The weird thing is that they got 10 thumbs up after the news on Linkedin, including from board member Andrew Molson. Strange.
Comment by Garp1 on Dec 05, 2022 11:10am
Birds of a feather stick together.
Comment by PinnacleX on Dec 05, 2022 12:21pm
There isnt anymore intrested "ears" just some of us read your posts more then once lol 
Comment by qwerty22 on Dec 05, 2022 1:14pm
I think this is one of many different strands that don't add up here. I'm putting that down to the fog of war rather than anything conspiratorial. I've seen PRs appear on their social media, this is just their usual MO. Right? I think I'm starting to settle on the idea that we are still mostly in the guesswork phase of things here. It helps to explain the complete lack of ...more  
Comment by PWIB123 on Dec 05, 2022 2:09pm
I can't wait for another few years to see something meaninful take place.  I have ownership in small businesses that will completely pay back an increase in my investment every 3-4 years.  I took the additional risk here for the big win, but this new series of events is going to have to make me rethink what I have left to leverage.  I'm still trying to process the signals ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities